Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib
2018
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related morbidity and mortality worldwide (1). Epidermal growth factor receptor ( EGFR ) mutations, as driver oncogenes, were first identified in NSCLC in 2004 (2).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
9
Citations
NaN
KQI